eli lilly tirzepatide trial Lilly's weight-loss drug reduces sleep apnea severity in late-stage trials Zepbound (tirzepatide) superior to Wegovy

SemaPen offers support for safe, licensed semaglutide treatments through its programme and that support is anchored in evidence-based dosing protocols that real trials confirm

Hormonal changes during perimenopause and menopause influence insulin sensitivity, appetite regulation, and medication tolerance

Not suitable for concentrations below 20 mg/mL at the 7.5 mg dose

A separate Phase 2 trial also published in The New England Journal of Medicine in 2023 evaluated retatrutide in adults with type 2 diabetes, reporting meaningful reductions in HbA1c alongside weight loss, with hypoglycaemia rates that were low in the absence of insulin or sulfonylurea co-administration

All three medications can affect menstrual cycles

A GLP-1 agonist is a medication designed to act like this hormone in your body